Novavax outlines $230M–$270M 2026 revenue target with new Pfizer partnership and cost reduction strategy [Seeking Alpha]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Seeking Alpha
John Jacobs, President and CEO, stated that "we made significant progress on our corporate strategy in 2025, successfully executing against our existing partnerships while advancing our organic pipeline, innovation efforts with our Matrix technology and Quick Insights Revenue targets have been raised to $230-270 million for 2026, with costs targeted at $200 million or below by 2028, indicating improved profitability and financial discipline. The Pfizer Matrix-M partnership and expanded Sanofi collaboration are expected to diversify revenue sources, drive milestone and royalty payments, and advance Novavax's transition to a partnership and R&D-driven model. Key risks include macro and regulatory uncertainties, timing of milestone realizations, dependence on partner commercialization success, and possible technology transfer delays. Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Novavax to Participate in Upcoming Investor ConferencesPR Newswire
- Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance]Yahoo! Finance
- Krispy Kreme stock skyrockets by nearly 30%, Shake Shake rising [Yahoo! Finance Canada]Yahoo! Finance Canada
- Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 2/26/26 - Form 8-K
- 2/26/26 - Form 10-K
- 2/11/26 - Form SCHEDULE
- NVAX's page on the SEC website